Heart Test Earnings Estimate

HSCS Stock  USD 3.28  0.33  11.19%   
By analyzing Heart Test's earnings estimates, investors can diagnose different trends across Heart Test's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Heart Test Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Heart Test is projected to generate -2.335 in earnings per share on the 31st of October 2024. Heart Test earnings estimates show analyst consensus about projected Heart Test Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on Heart Test's historical volatility. Many public companies, such as Heart Test, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Heart Test's earnings estimates, investors can diagnose different trends across Heart Test's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to 8,643 in 2024. Pretax Profit Margin is likely to drop to -372.87 in 2024
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Heart Test Earnings per Share Projection vs Actual

About Heart Test Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Heart Test earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Heart Test estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Heart Test fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-67.4 M-70.7 M
Earnings Yield(2.03)(2.13)
Price Earnings Ratio(0.49)(0.52)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.